Illumina, Inc. (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Illumina, Inc." in English language version.

refsWebsite

Global rank English rank

55web.archive.org

1^st place

8reuters.com

49^th place

47^th place

5genomeweb.com

low place

5illumina.com

low place

4wsj.com

79^th place

65^th place

3biospace.com

low place

7,595^th place

2archive.today

14^th place

2roche.com

low place

2wired.com

193^rd place

152^nd place

2technologyreview.com

1,943^rd place

1,253^rd place

2cnbc.com

220^th place

155^th place

2ftc.gov

3,796^th place

2,268^th place

2fiercebiotech.com

low place

8,828^th place

2doi.org

2^nd place

2law360.com

6,282^nd place

3,410^th place

2endpts.com

low place

2nih.gov

4^th place

1sec.gov

572^nd place

436^th place

1linkedin.com

895^th place

692^nd place

1cnn.com

28^th place

26^th place

1theguardian.com

12^th place

11^th place

1patentlens.net

low place

1everygenome.com

low place

1fda.gov

447^th place

338^th place

1xconomy.com

low place

6,978^th place

1economist.com

254^th place

236^th place

1wired.co.uk

2,053^rd place

1,340^th place

1timesofsandiego.com

low place

7,560^th place

1forbes.com

54^th place

48^th place

1startribune.com

914^th place

530^th place

1fool.com

4,183^rd place

2,600^th place

1europa.eu

68^th place

117^th place

1nytimes.com

7^th place

1sandiegouniontribune.com

1,275^th place

722^nd place

1harvard.edu

18^th place

17^th place

1ibiology.org

low place

1techtransfercentral.com

low place

1semanticscholar.org

11^th place

8^th place

1frontlinegenomics.com

low place

1medtechdive.com

low place

archive.today

Kawashima, Eric H.; Laurent Farinelli; Pascal Mayer (2005-05-12). "Patent: Method of nucleic acid amplification". Archived from the original on 2013-02-22. Retrieved 2012-12-22.
"Illumina .::. Investor Relations News Release". Investor.illumina.com. 2011-01-11. Archived from the original on 2013-11-21. Retrieved 2014-01-18.

biospace.com

"Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific Discovery". BioSpace. Archived from the original on 2019-06-04. Retrieved 2019-06-04.
"Illumina Acquires Pacific Biosciences for $1.2 Billion". BioSpace. Archived from the original on 2019-01-15. Retrieved 2018-11-03.
"Illumina Files Additional Patent Infringement Suit Against BGI in the U.S." BioSpace. Archived from the original on 2020-08-01. Retrieved 2021-01-13.

cnbc.com

Farr, Christina (2020-09-21). "Illumina buys Jeff Bezos-backed cancer-testing firm Grail in deal worth $8 billion". CNBC. Archived from the original on 2020-09-29. Retrieved 2020-09-22.
"Illumina abandons $1.2 billion deal to buy rival Pacific Biosciences". CNBC. 2020-01-02. Archived from the original on 2020-01-03. Retrieved 2020-01-03.

cnn.com

money.cnn.com

Stipp, David (3 Apr 2000). "13 Biotech IPOs To Watch For". Fortune. Retrieved 4 Nov 2019.

doi.org

Bentley, David R.; et al. (6 November 2008). "Accurate whole human genome sequencing using reversible terminator chemistry". Nature. 456 (7218): 53–59. Bibcode:2008Natur.456...53B. doi:10.1038/nature07517. PMC 2581791. PMID 18987734.
Check Hayden, Erika (25 February 2016). "Fight brews over promising genetic-sequencing technology". Nature: nature.2016.19451. doi:10.1038/nature.2016.19451. S2CID 211836642.

economist.com

Roche and Illumina: Taking it personally Archived 2018-02-06 at the Wayback Machine. The Economist (2012-04-18). Retrieved on 2013-09-05.

endpts.com

Patchen, Tyler. "Illumina forced to pay almost $334M as it loses DNA sequencing patent case". Endpoints News. Archived from the original on 2022-05-09. Retrieved 2022-05-10.
"Guardant Health fires back at Illumina suit, claiming retaliation over its role in FTC antitrust investigation". Endpoints News. Archived from the original on 2022-10-20. Retrieved 2022-10-20.

europa.eu

ec.europa.eu

"Press corner". European Commission - European Commission. Archived from the original on 2019-06-21. Retrieved 2021-12-28.

everygenome.com

Everygenome.com: Individual genome sequencing - Illumina, Inc. Archived 2011-10-19 at the Wayback Machine

fda.gov

accessdata.fda.gov

"510(k) Premarket Notification K093128". FDA. Archived from the original on 4 November 2020. Retrieved 7 April 2017.

fiercebiotech.com

"Illumina completes Grail acquisition, regulators be damned". FierceBiotech. 19 August 2021. Archived from the original on 2021-12-28. Retrieved 2021-12-28.
Hale, Conor (September 30, 2022). "Illumina pitches $200 genomes with new line of DNA sequencers". FierceBiotech. Archived from the original on February 23, 2023. Retrieved February 8, 2023.

fool.com

Swanson, Cheryl (2017-04-30). "Are Jeff Bezos and Bill Gates Wrong About Illumina? -- The Motley Fool". The Motley Fool. Archived from the original on 2020-10-25. Retrieved 2017-04-30.

forbes.com

Herper, Matthew. "Company Will Raise $1 Billion To Create Blood Test To Detect Cancer". Forbes. Archived from the original on 2020-12-06. Retrieved 2017-04-30.

frontlinegenomics.com

"Illumina sues Oxford Nanopore for patent infringement".^{[permanent dead link‍]}

ftc.gov

"FTC Challenges Illumina's Proposed Acquisition of PacBio". Federal Trade Commission. 17 December 2019. Archived from the original on 30 March 2021. Retrieved 31 March 2021.
"FTC Challenges Illumina's Proposed Acquisition of Cancer Detection Test Maker Grail". Federal Trade Commission. 30 March 2021. Archived from the original on 30 March 2021. Retrieved 31 March 2021.

genomeweb.com

Petrone, Justin (May 4, 2010). "FDA Clears Illumina's BeadXpress System for Clinical Use". GenomeWeb. Archived from the original on November 4, 2020. Retrieved April 7, 2017.
"Big Array Vendors Promise New Chips, Acquisitions, and Diagnostics in 2009". GenomeWeb. January 6, 2009. Archived from the original on September 11, 2019. Retrieved April 7, 2017.
Staff (15 July 2020). "Illumina Acquires French Genomic Data-Compression Startup Enancio". GenomeWeb. New York City: Crain Communications. Archived from the original on 17 July 2020. Retrieved 16 July 2020.
"Illumina and Oxford Nanopore Settle Patent Infringement Lawsuit". GenomeWeb. 25 August 2016. Archived from the original on 2021-01-14. Retrieved 2021-01-13.
"BGI Sues Illumina for Antitrust Violation, Claims Firm Obtained Sequencing Patents Through Fraud". GenomeWeb. 11 January 2021. Archived from the original on 2021-01-11. Retrieved 2021-01-13.

harvard.edu

ui.adsabs.harvard.edu

Bentley, David R.; et al. (6 November 2008). "Accurate whole human genome sequencing using reversible terminator chemistry". Nature. 456 (7218): 53–59. Bibcode:2008Natur.456...53B. doi:10.1038/nature07517. PMC 2581791. PMID 18987734.

ibiology.org

"Next Generation Sequencing • iBiology". iBiology. Archived from the original on 2020-08-01. Retrieved 2020-05-15.

illumina.com

"History of Illumina Sequencing". illumina.com. Archived from the original on 2017-02-02. Retrieved 2017-01-25.
"Illumina sequencing platforms". Illumina. Archived from the original on February 4, 2023. Retrieved February 8, 2023.
"NextSeq 1000 and NextSeq 2000 Overview". Illumina. Archived from the original on February 8, 2023. Retrieved February 8, 2023.
"NovaSeq X and NovaSeq X Plus Sequencing Systems" (PDF). Illumina. Archived (PDF) from the original on February 8, 2023. Retrieved February 8, 2023.

investor.illumina.com

"Illumina .::. Investor Relations News Release". Investor.illumina.com. 2011-01-11. Archived from the original on 2013-11-21. Retrieved 2014-01-18.

law360.com

Bayles, Cara (23 January 2018). "Illumina, Ariosa Seek Tens Of Millions As IP Trial Ends". Law360. Archived from the original on 8 October 2022. Retrieved 8 October 2022.
Kass, Dani (24 May 2021). "Ariosa, Illumina Resolve DNA Patent Dispute At High Court". Law360. Archived from the original on 8 October 2022. Retrieved 8 October 2022.

linkedin.com

"Illumina- The Origin story". www.linkedin.com. Archived from the original on 2024-05-10. Retrieved 2020-10-05.

medtechdive.com

"Illumina sues Guardant CEOs over trade secrets, sparking counterblast against 'retaliatory' lawsuit". MedTech Dive. Archived from the original on 2022-10-20. Retrieved 2022-10-20.

nih.gov

ncbi.nlm.nih.gov

Bentley, David R.; et al. (6 November 2008). "Accurate whole human genome sequencing using reversible terminator chemistry". Nature. 456 (7218): 53–59. Bibcode:2008Natur.456...53B. doi:10.1038/nature07517. PMC 2581791. PMID 18987734.

pubmed.ncbi.nlm.nih.gov

Bentley, David R.; et al. (6 November 2008). "Accurate whole human genome sequencing using reversible terminator chemistry". Nature. 456 (7218): 53–59. Bibcode:2008Natur.456...53B. doi:10.1038/nature07517. PMC 2581791. PMID 18987734.

nytimes.com

Lohr, Steve (3 April 2023). "F.T.C. Orders Gene-Sequencing Company Illumina to Divest Acquisition". The New York Times. Archived from the original on 4 April 2023. Retrieved 4 April 2023.

patentlens.net

Kawashima, Eric H.; Laurent Farinelli; Pascal Mayer (2005-05-12). "Patent: Method of nucleic acid amplification". Archived from the original on 2013-02-22. Retrieved 2012-12-22.

reuters.com

Scarcella, Mike (2021-08-24). "FTC urges judge to unwind $7.1 bln Illumina-Grail merger". Reuters. Archived from the original on 2021-12-28. Retrieved 2021-12-28.
"EU orders Illumina to keep Grail a separate company". Reuters. 2021-10-29. Retrieved 2021-12-28.
Chee, Foo Yun (12 July 2023). "Illumina hit with record $476 million EU antitrust fine over Grail deal". Reuters. Archived from the original on 2023-07-13. Retrieved 2023-07-13.
"Illumina expands board after fight with Icahn". Reuters. June 2, 2023. Archived from the original on 2023-08-10. Retrieved 2023-08-09.
Chee, Foo Yun (October 12, 2023). "Illumina ordered by EU antitrust regulators to sell Grail". Reuters. Archived from the original on 2023-10-19. Retrieved 2023-10-14.
Roy, Sriparna (October 13, 2023). "Illumina to divest Grail within a year if it does not win challenge in EU court". Reuters.
Brittain, Blake (2022-05-07). "Illumina ordered to pay BGI subsidiary $333 million in DNA-sequencing patent case". Reuters. Archived from the original on 2022-05-11. Retrieved 2022-05-07.

uk.reuters.com

"Illumina to buy Jeff Bezos-backed cancer testing firm Grail in £6.23 billion deal". Reuters. 21 September 2020.^{[dead link‍]}

roche.com

"Roche - Roche offers to acquire all outstanding shares of Illumina, Inc. to further strengthen its leading role in diagnostics". Archived from the original on 2012-02-28. Retrieved 2012-03-07.
Roche decides not to extend its tender offer for Illumina, Inc. Archived 2014-08-08 at the Wayback Machine

sandiegouniontribune.com

Rocha, Natallie (September 6, 2023). "San Diego has a new CEO in town. Here's what financial analysts are saying about Illumina's next leader". San Diego Union-Tribune. Archived from the original on November 8, 2023. Retrieved November 8, 2023.

sec.gov

"US SEC:Form 10-K Illumina, Inc". U.S. Securities and Exchange Commission. 16 February 2024. Archived from the original on 17 February 2024. Retrieved 17 February 2024.

semanticscholar.org

api.semanticscholar.org

Check Hayden, Erika (25 February 2016). "Fight brews over promising genetic-sequencing technology". Nature: nature.2016.19451. doi:10.1038/nature.2016.19451. S2CID 211836642.

startribune.com

"Mayo Clinc scientists on the trail of a 'pan cancer' test". Star Tribune. Archived from the original on 2020-08-09. Retrieved 2017-04-30.

technologyreview.com

Zimmerman, Eilene (18 February 2014). "50 Smartest Companies: Illumina". MIT Technology Review. Massachusetts Institute of Technology. Archived from the original on 11 December 2015. Retrieved 25 August 2014.
Regalado, Antonio. "EmTech: Illumina Says 228,000 Human Genomes Will Be Sequenced This Year". MIT Technology Review. Massachusetts Institute of Technology. Archived from the original on 26 December 2015. Retrieved 26 September 2014.

techtransfercentral.com

"Cornell revives previously settled patent infringement lawsuit against Illumina". 20 September 2017. Archived from the original on 18 May 2018. Retrieved 8 July 2018.

theguardian.com

Devlin, Hannah (3 April 2020). "Why has the UK lagged behind in testing for the Coronavirus?". The Guardian. Archived from the original on 10 May 2024. Retrieved 21 April 2020.

timesofsandiego.com

Stone, Ken (March 7, 2016). "Illumina likes Francis deSouza's DNA, elevating president to CEO". Times of San Diego. Archived from the original on December 4, 2022. Retrieved November 8, 2023.

web.archive.org

"US SEC:Form 10-K Illumina, Inc". U.S. Securities and Exchange Commission. 16 February 2024. Archived from the original on 17 February 2024. Retrieved 17 February 2024.
Morrison, Mary E. (May 31, 2023). "At Illumina, Breaking DownBarriers to Democratize Genomics". Wall Street Journal. Deloitte. Archived from the original on November 8, 2023. Retrieved November 8, 2023.
"Illumina- The Origin story". www.linkedin.com. Archived from the original on 2024-05-10. Retrieved 2020-10-05.
Devlin, Hannah (3 April 2020). "Why has the UK lagged behind in testing for the Coronavirus?". The Guardian. Archived from the original on 10 May 2024. Retrieved 21 April 2020.
"History of Illumina Sequencing". illumina.com. Archived from the original on 2017-02-02. Retrieved 2017-01-25.
Everygenome.com: Individual genome sequencing - Illumina, Inc. Archived 2011-10-19 at the Wayback Machine
Petrone, Justin (May 4, 2010). "FDA Clears Illumina's BeadXpress System for Clinical Use". GenomeWeb. Archived from the original on November 4, 2020. Retrieved April 7, 2017.
"510(k) Premarket Notification K093128". FDA. Archived from the original on 4 November 2020. Retrieved 7 April 2017.
"Big Array Vendors Promise New Chips, Acquisitions, and Diagnostics in 2009". GenomeWeb. January 6, 2009. Archived from the original on September 11, 2019. Retrieved April 7, 2017.
"Roche - Roche offers to acquire all outstanding shares of Illumina, Inc. to further strengthen its leading role in diagnostics". Archived from the original on 2012-02-28. Retrieved 2012-03-07.
"Xconomy: Five Reasons Illumina Should Fight Roche's Insulting Low-Ball Bid". Xconomy. 5 March 2012. Archived from the original on 10 May 2024. Retrieved 4 June 2019.
Roche and Illumina: Taking it personally Archived 2018-02-06 at the Wayback Machine. The Economist (2012-04-18). Retrieved on 2013-09-05.
Roche decides not to extend its tender offer for Illumina, Inc. Archived 2014-08-08 at the Wayback Machine
Clark, Liat (15 Jan 2014). "Illumina announces landmark $1,000 human genome sequencing". Wired. Archived from the original on 4 November 2019. Retrieved 4 Nov 2019.
Molteni, Megan (19 Nov 2018). "Now You Can Sequence Your Whole Genome for Just $200". Wired. Archived from the original on 8 November 2020. Retrieved 4 Nov 2019.
Zimmerman, Eilene (18 February 2014). "50 Smartest Companies: Illumina". MIT Technology Review. Massachusetts Institute of Technology. Archived from the original on 11 December 2015. Retrieved 25 August 2014.
Regalado, Antonio. "EmTech: Illumina Says 228,000 Human Genomes Will Be Sequenced This Year". MIT Technology Review. Massachusetts Institute of Technology. Archived from the original on 26 December 2015. Retrieved 26 September 2014.
Staff (15 July 2020). "Illumina Acquires French Genomic Data-Compression Startup Enancio". GenomeWeb. New York City: Crain Communications. Archived from the original on 17 July 2020. Retrieved 16 July 2020.
Stone, Ken (March 7, 2016). "Illumina likes Francis deSouza's DNA, elevating president to CEO". Times of San Diego. Archived from the original on December 4, 2022. Retrieved November 8, 2023.
Herper, Matthew. "Company Will Raise $1 Billion To Create Blood Test To Detect Cancer". Forbes. Archived from the original on 2020-12-06. Retrieved 2017-04-30.
"Mayo Clinc scientists on the trail of a 'pan cancer' test". Star Tribune. Archived from the original on 2020-08-09. Retrieved 2017-04-30.
Swanson, Cheryl (2017-04-30). "Are Jeff Bezos and Bill Gates Wrong About Illumina? -- The Motley Fool". The Motley Fool. Archived from the original on 2020-10-25. Retrieved 2017-04-30.
Farr, Christina (2020-09-21). "Illumina buys Jeff Bezos-backed cancer-testing firm Grail in deal worth $8 billion". CNBC. Archived from the original on 2020-09-29. Retrieved 2020-09-22.
"Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific Discovery". BioSpace. Archived from the original on 2019-06-04. Retrieved 2019-06-04.
"Illumina Acquires Pacific Biosciences for $1.2 Billion". BioSpace. Archived from the original on 2019-01-15. Retrieved 2018-11-03.
"FTC Challenges Illumina's Proposed Acquisition of PacBio". Federal Trade Commission. 17 December 2019. Archived from the original on 30 March 2021. Retrieved 31 March 2021.
"Illumina abandons $1.2 billion deal to buy rival Pacific Biosciences". CNBC. 2020-01-02. Archived from the original on 2020-01-03. Retrieved 2020-01-03.
Kendall, Brent; Rockoff, Jonathan D. (31 March 2021). "FTC Seeks to Block Illumina's $7.1 Billion Acquisition of Life Sciences Firm Grail". Wall Street Journal. Archived from the original on 30 March 2021. Retrieved 31 March 2021.
"FTC Challenges Illumina's Proposed Acquisition of Cancer Detection Test Maker Grail". Federal Trade Commission. 30 March 2021. Archived from the original on 30 March 2021. Retrieved 31 March 2021.
"Press corner". European Commission - European Commission. Archived from the original on 2019-06-21. Retrieved 2021-12-28.
"Illumina completes Grail acquisition, regulators be damned". FierceBiotech. 19 August 2021. Archived from the original on 2021-12-28. Retrieved 2021-12-28.
Scarcella, Mike (2021-08-24). "FTC urges judge to unwind $7.1 bln Illumina-Grail merger". Reuters. Archived from the original on 2021-12-28. Retrieved 2021-12-28.
Loftus, Peter (1 September 2022). "Illumina Wins Case Against FTC on Grail Acquisition". The Wall Street Journal. Archived from the original on 1 September 2022. Retrieved 1 September 2022.
Lohr, Steve (3 April 2023). "F.T.C. Orders Gene-Sequencing Company Illumina to Divest Acquisition". The New York Times. Archived from the original on 4 April 2023. Retrieved 4 April 2023.
Chee, Foo Yun (12 July 2023). "Illumina hit with record $476 million EU antitrust fine over Grail deal". Reuters. Archived from the original on 2023-07-13. Retrieved 2023-07-13.
Mullin, Emily (September 29, 2022). "The Era of Fast, Cheap Genome Sequencing Is Here". Wired. Archived from the original on February 8, 2023. Retrieved February 8, 2023.
Hale, Conor (September 30, 2022). "Illumina pitches $200 genomes with new line of DNA sequencers". FierceBiotech. Archived from the original on February 23, 2023. Retrieved February 8, 2023.
Loftus, Peter (June 11, 2023). "Illumina CEO Francis deSouza Resigns Amid Regulatory Hurdles, Proxy Fight". Wall Street Journal. Archived from the original on June 16, 2023. Retrieved June 16, 2023.
"Illumina expands board after fight with Icahn". Reuters. June 2, 2023. Archived from the original on 2023-08-10. Retrieved 2023-08-09.
Rocha, Natallie (September 6, 2023). "San Diego has a new CEO in town. Here's what financial analysts are saying about Illumina's next leader". San Diego Union-Tribune. Archived from the original on November 8, 2023. Retrieved November 8, 2023.
Chee, Foo Yun (October 12, 2023). "Illumina ordered by EU antitrust regulators to sell Grail". Reuters. Archived from the original on 2023-10-19. Retrieved 2023-10-14.
"Illumina sequencing platforms". Illumina. Archived from the original on February 4, 2023. Retrieved February 8, 2023.
"NextSeq 1000 and NextSeq 2000 Overview". Illumina. Archived from the original on February 8, 2023. Retrieved February 8, 2023.
"NovaSeq X and NovaSeq X Plus Sequencing Systems" (PDF). Illumina. Archived (PDF) from the original on February 8, 2023. Retrieved February 8, 2023.
"Next Generation Sequencing • iBiology". iBiology. Archived from the original on 2020-08-01. Retrieved 2020-05-15.
"Cornell revives previously settled patent infringement lawsuit against Illumina". 20 September 2017. Archived from the original on 18 May 2018. Retrieved 8 July 2018.
Bayles, Cara (23 January 2018). "Illumina, Ariosa Seek Tens Of Millions As IP Trial Ends". Law360. Archived from the original on 8 October 2022. Retrieved 8 October 2022.
Kass, Dani (24 May 2021). "Ariosa, Illumina Resolve DNA Patent Dispute At High Court". Law360. Archived from the original on 8 October 2022. Retrieved 8 October 2022.
"Illumina and Oxford Nanopore Settle Patent Infringement Lawsuit". GenomeWeb. 25 August 2016. Archived from the original on 2021-01-14. Retrieved 2021-01-13.
"Illumina Files Additional Patent Infringement Suit Against BGI in the U.S." BioSpace. Archived from the original on 2020-08-01. Retrieved 2021-01-13.
"BGI Sues Illumina for Antitrust Violation, Claims Firm Obtained Sequencing Patents Through Fraud". GenomeWeb. 11 January 2021. Archived from the original on 2021-01-11. Retrieved 2021-01-13.
Brittain, Blake (2022-05-07). "Illumina ordered to pay BGI subsidiary $333 million in DNA-sequencing patent case". Reuters. Archived from the original on 2022-05-11. Retrieved 2022-05-07.
Patchen, Tyler. "Illumina forced to pay almost $334M as it loses DNA sequencing patent case". Endpoints News. Archived from the original on 2022-05-09. Retrieved 2022-05-10.
"Illumina sues Guardant CEOs over trade secrets, sparking counterblast against 'retaliatory' lawsuit". MedTech Dive. Archived from the original on 2022-10-20. Retrieved 2022-10-20.
"Guardant Health fires back at Illumina suit, claiming retaliation over its role in FTC antitrust investigation". Endpoints News. Archived from the original on 2022-10-20. Retrieved 2022-10-20.

wired.co.uk

Clark, Liat (15 Jan 2014). "Illumina announces landmark $1,000 human genome sequencing". Wired. Archived from the original on 4 November 2019. Retrieved 4 Nov 2019.

wired.com

Molteni, Megan (19 Nov 2018). "Now You Can Sequence Your Whole Genome for Just $200". Wired. Archived from the original on 8 November 2020. Retrieved 4 Nov 2019.
Mullin, Emily (September 29, 2022). "The Era of Fast, Cheap Genome Sequencing Is Here". Wired. Archived from the original on February 8, 2023. Retrieved February 8, 2023.

wsj.com

Kendall, Brent; Rockoff, Jonathan D. (31 March 2021). "FTC Seeks to Block Illumina's $7.1 Billion Acquisition of Life Sciences Firm Grail". Wall Street Journal. Archived from the original on 30 March 2021. Retrieved 31 March 2021.
Loftus, Peter (1 September 2022). "Illumina Wins Case Against FTC on Grail Acquisition". The Wall Street Journal. Archived from the original on 1 September 2022. Retrieved 1 September 2022.
Loftus, Peter (June 11, 2023). "Illumina CEO Francis deSouza Resigns Amid Regulatory Hurdles, Proxy Fight". Wall Street Journal. Archived from the original on June 16, 2023. Retrieved June 16, 2023.

deloitte.wsj.com

Morrison, Mary E. (May 31, 2023). "At Illumina, Breaking DownBarriers to Democratize Genomics". Wall Street Journal. Deloitte. Archived from the original on November 8, 2023. Retrieved November 8, 2023.

xconomy.com

"Xconomy: Five Reasons Illumina Should Fight Roche's Insulting Low-Ball Bid". Xconomy. 5 March 2012. Archived from the original on 10 May 2024. Retrieved 4 June 2019.